Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, while Wegovy contains semaglutide
Users who do not adjust their meal timing at this dose are the most likely to develop insomnia
"Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: A randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial." The Lancet , 402(10404), 529-544
Pulmonology For respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and infectious pulmonary conditions, inhalable liposomal formulations provide localized delivery to lung tissues
Am Rev Respir Dis 148 : 11741178 Schmidt R, Luboeinski T, Markart P, Ruppert C, Daum C, Grimminger F, Seeger W, Gunther A 2004 Alveolar antioxidant status in patients with acute respiratory distress syndrome